Health

The Power of Truth^® has been released for sale and assignment to a conservative pro-American news outlet, cable network, or other media outlet that wants to define and brand its operation as the bearer of the truth, and set itself above the competition.

In every news story the audience hears of censorship, speech, and the truth. The Power of Truth^® has significant value to define an outlet, and expand its audience. A growing media outlet may decide to rebrand their operation The Power of Truth^®. An established outlet may choose to make it the slogan distinguishing their operation from the competition. You want people to think of your outlet when they hear it, and think of the slogan when they see your company name. It is the thing which answers the consumer's questions: Why should I choose you? Why should I listen to you? Think:

What’s in your wallet -- Capital One
The most trusted name in news – CNN
Fair and balanced - Fox News
Where’s the beef -- Wendy’s
You’re in good hands -- Allstate
The ultimate driving machine -- BMW

The Power of Truth^® is registered at the federal trademark level in all applicable trademark classes, and the sale and assignment includes the applicable domain names. The buyer will have both the trademark and the domains so that it will control its business landscape without downrange interference.

Contact: Truth@ThePowerOfTruth.com

Sidebar

Magazine menu

The Power of Truth^®

Tuesday, December 24, 2024

Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challenges

On June 13, 2024, the Supreme Court of the United States unanimously decided to uphold access ^[1] to mifepristone, one of two pills ^[2] used in medication abortion. Mifepristone has long been used safely and effectively in medication abortions around the world ^[3].

Shortly after the 2022 Dobbs decision that overturned 50 years of abortion rights, anti-abortion groups and doctors challenged ^[4] the Food and Drug Administration’s 2000...

Only one in 20 therapies tested in animals reach approval for human use

An analysis of reviews of translational biomedical research reveals that just 5% of therapies tested in animals reach regulatory approval for human use. The umbrella review summarizes other systematic reviews and provides high level evidence that while the rate of translation to human studies is 50%, there is steep drop off before final approval.

Can engineered plants help make baby formula as nutritious as breast milk?

New research may help close the nutrition gap between infant formula and human breast milk. The study shows how plants can be programmed to produce a diverse array of beneficial sugars found in human breast milk. The findings could lead to healthier and more affordable formula for babies, or more nutritious non-dairy plant milk for adults.

Short-term loneliness associated with physical health problems

Loneliness may be harmful to our daily health, according to a new study focused on understanding the subtleties of loneliness and how variations in daily feelings of loneliness effect short- and long-term well-being. The researchers said the work provides more evidence in support of the devastating impact of loneliness and isolation on physical health in the country, calling it a public health crisis.

More Articles …

HUNGRY FOR TRUTH? FEED THE NEED.